- Meeting abstract
- Open Access
The perioperative course of C1-esterase-inhibitor: evidence for an early deficiency
Critical Care volume 3, Article number: P081 (2000)
Since the extent of complement-and contact-activation and a low functional index of their main inactivator C1-esterase-inhibitor (C1-INH) are related to outcome in sepsis, a relative deficiency of C1-INH might contribute to the development of fatal complications. At present few data on the periperative course of C1-INH plasma levels have been published. In our study the early perioperative course of C1-INH in relation to the acute phase protein interleukin-6 (IL-6) was investigated in order to assess one possible important aspect of the balance between anti-and proinflammatory mediators.
In 19 consecutive patients undergoing elective oropharynx tumorresection functional C1-INH was measured by chromogenic substrate assay Berichrom® C1-Inactivator, the total quantity by single radial imunodiffusion assay NOR-Partigen® and cytokine IL-6 levels by MEDGENIX IL-6-45 MIN-EASIA. Samples were taken before operation (tl), on ICU admission (t2) and on the first postoperative day (t3).
The mean operation time was 9 h (range: 4:05 to 14:40 h) and all patients showed an uncomplicated ICU course up to 86 h. IL-6 levels increased from t1 to t2 (P < 0.01), whereas C1-INH functional levels declined tendencially and antigenic levels dropped (P = 0.024). Levels of C1-INH at t3 returned to preoperative values and IL-6 declined.
As expected (postoperative agression syndrome) IL-6 increased significantly. Surprisingly, plasma levels of the anti-inflammatory acute phase protein C1-INH remained normal or even declined. On the first postoperative day C1-INH and IL-6 levels tended to return to preoperative values. This was associated with uncomplicated clinical course. We suggest, that this short period of disproportion between pro- and anti-inflammatory mediators may increase the `second hit' risk, if it is longer lasting.
About this article
Cite this article
Cobas Meyer, M., Marx, G., Vangerow, B. et al. The perioperative course of C1-esterase-inhibitor: evidence for an early deficiency. Crit Care 3, P081 (2000). https://doi.org/10.1186/cc455
- Acute Phase Protein
- Chromogenic Substrate
- Proinflammatory Mediator
- Antigenic Level
- Fatal Complication